Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00315_DB00752> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00315_DB00752 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00752 label "DDI between Zolmitriptan and Tranylcypromine - The MAO inhibitor, tranylcypromine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing tranylcypromine are contraindicated. [drugbank_resource:DB00315_DB00752]" assertion.
- drugbank_resource:DB00315_DB00752 identifier "drugbank_resource:DB00315_DB00752" assertion.
- drugbank_resource:DB00315_DB00752 title "DDI between Zolmitriptan and Tranylcypromine - The MAO inhibitor, tranylcypromine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing tranylcypromine are contraindicated." assertion.